Imaging data transfer methods ‘chaotic and disjointed’

Oncology NEWS InternationalOncology NEWS International Vol 17 No 3
Volume 17
Issue 3

Some clinicians are so discouraged by nonstandard CD-ROMs generated at imaging centers they are calling on the radiology community to improve the way it transfers imaging data to referring physicians.

Some clinicians are so discouraged by nonstandard CD-ROMs generated at imaging centers they are calling on the radiology community to improve the way it transfers imaging data to referring physicians.

Douglas W. Blayney, MD, medical director of the University of Michigan Comprehensive Cancer Center, and ASCO president-elect, said the imaging community needs to improve its “chaotic and disjointed transfer methods.”

Clinician frustration stems from difficulties attempting to open CD-ROMs given to patients at imaging facilities to present to their physicians.

“As a clinical oncologist, I not only use diagnostic images to make treatment decisions but, most important, to demonstrate to my patients the effects of treatment on their tumors,” Dr. Blayney said in an interview. Almost every day, a patient brings him a CD-ROM with images from a recent CT, MRI, or PET scan, and he is unable to share the images with the patient, he said.

“Although most discs come with image viewing software as an executable file (.exe), our antivirus software prohibits us from loading executable files onto our desktop computers,” he said.

Dr. Blayney, who is also editor of ASCO’s Journal of Oncology Practice, said these snags interfere with patient care, slow him down, and distract from the time and energy he devotes to patients. He recently detailed his concerns with outside CD-ROMs (From the editor’s desk. J Oncol Pract 4[1]:1, 2008).

The standard for diagnostic image interchange is DICOM, yet many radiology clinics burn discs as JPEGs or in an otherwise proprietary format.

Richard K. J. Brown, MD, director of general clinical nuclear imaging at Michigan University Hospital, said that JPEG images may look good, but they do not contain the diagnostic depth that the DICOM format allows.

“My diagnostic radiology colleagues have taught me to adjust the window and level of images to bring out details in bone, soft tissue, and lung, but many of the proprietary formats we receive on CD-ROMs don’t allow for this type of interaction,” Dr. Brown said.

Dr. Blayney recommends that imaging centers burn data on CDs in DICOM format and that a DICOM viewer be included on the disc so clinicians can also view images on their home computer.

Eventually, he would like to see CD-ROMs eliminated altogether.

“I would like to get to a place where we exchange clinical data with the efficiency of the banking and travel industries,” Dr. Blayney said.

He noted that his financial institution lets him see not only his bank balances and portfolios but also, from the same screen, his transactions and valuations of mutual funds held with other companies.

“They also allow me to view images of handwritten checks without loading them onto my computer’s hard drive,” Dr. Blayney said. “This is a service I would like to see provided by my diagnostic imaging facilities.”

Related Videos
Experts on multiple myeloma
Sara M. Tolaney, MD, MPH, discusses how, compared with antibody-drug conjugates, chemotherapy produces low response rates and disease control in the treatment of those with hormone receptor–positive, HER2-negative metastatic breast cancer.
Experts on multiple myeloma
Hope Rugo, MD, speaks to the importance of identifying patients with aromatase inhibitor–resistant, hormone receptor–positive, HER2-negative advanced breast cancer who are undergoing treatment with capivasertib/fulvestrant who may be at a high risk of developing diabetes or hyperglycemia.
Sara M. Tolaney, MD, MPH, describes the benefit of sacituzumab govitecan for patients with HER2-low metastatic breast cancer seen in the final overall survival analysis of the phase 3 TROPiCS-02 study.
Experts on MM
Experts on colorectal cancer
Experts on MM
An expert from Vanderbilt University Medical Center says that patients with relapsed/refractory multiple myeloma may be able to live a normal life following response to salvage treatment with bispecific monoclonal antibodies.
Experts on multiple myeloma